CausalSentinel

Protein Dossier — CDSN (Corneodesmosin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Body mass index (BMI) -0.0215 0.00657 0.00107 Inverse variance weighted 2 trans NA
Body mass index (BMI) -0.0215 0.00657 0.00107 Inverse variance weighted 2 trans NA
Weight -0.0177 0.00581 0.00235 Inverse variance weighted 2 trans NA
Weight -0.0177 0.00581 0.00235 Inverse variance weighted 2 trans NA
Major depressive disorder -0.179 0.0612 0.0035 Inverse variance weighted 2 trans NA
Major depressive disorder -0.179 0.0612 0.0035 Inverse variance weighted 2 trans NA
Childhood intelligence -0.151 0.0558 0.00665 Wald ratio 1 trans NA
Diagnoses - main ICD10: R04 Haemorrhage from respiratory passages 0.177 0.0771 0.0215 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R04 Haemorrhage from respiratory passages 0.177 0.0771 0.0215 Inverse variance weighted 2 trans NA
Urinary albumin-to-creatinine ratio -0.0397 0.0184 0.0312 Inverse variance weighted 2 trans NA
Urinary albumin-to-creatinine ratio -0.0397 0.0184 0.0312 Inverse variance weighted 2 trans NA
Years of schooling -0.0423 0.0199 0.0339 Inverse variance weighted 2 trans NA
…and 186 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

27 association rows across 25 traits (23 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Primary sclerosing cholangitis (MTAG) 1e-61 rs3094210 1 GCST90271580 no MR -> candidate analysis
Hemoglobin levels 5e-44 rs34182778 1 GCST010083 no MR -> candidate analysis
KIR2DL2 protein levels 7e-33 rs115510688 1 GCST90469684 no MR -> candidate analysis
PLB1 protein levels 1e-27 rs9501053 1 GCST90470253 no MR -> candidate analysis
Polyunsaturated fatty acid levels 1e-24 rs3130988 1 GCST90502134 no MR -> candidate analysis
FCRL1/TNFRSF13C protein level ratio 1e-21 rs1265045 1 GCST90314796 no MR -> candidate analysis
Omega-6 fatty acid levels 2e-21 rs3130988 1 GCST90502095 no MR -> candidate analysis
Mouth ulcers 3e-20 rs78479381 1 GCST007839 no MR -> candidate analysis
FEV1 x serum 25-hydroxyvitamin D interaction in never smoker 1e-19 rs3130985 1 GCST90590340 no MR -> candidate analysis
Psoriasis 6e-16 rs3130982 x rs9366778 1 GCST007023 MR: beta=-0.0548, p=0.404 (trans)
MHC class I polypeptide-related sequence B levels 4e-15 rs3130991 1 GCST90101317 no MR -> candidate analysis
Height 1e-14 rs1042127 1 GCST90245848 no MR -> candidate analysis
…and 13 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1125 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
peeling skin syndrome 1 0.778 established (curated) no MR -> candidate analysis
hypotrichosis 2 0.707 established (curated) no MR -> candidate analysis
hypotrichosis simplex of the scalp 0.608 established (curated) no MR -> candidate analysis
hereditary disease 0.316 established (curated) no MR -> candidate analysis

Of the 4 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.2, LOEUF=0.712 — LoF-tolerant
GWAS Catalog 843 unique SNPs / 2456 rows
ClinVar 179 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 2 drugs

Caveats declared by the tools

Sources

Provenance